Caribou Biosciences Inc (NASDAQ: CRBU) on Tuesday, plunged -5.14% from the previous trading day, before settling in for the closing price of $2.14. Within the past 52 weeks, CRBU’s price has moved between $1.50 and $8.33.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 71.11% over the last five years. The company achieved an average annual earnings per share of -20.17%. With a float of $79.16 million, this company’s outstanding shares have now reached $90.55 million.
The firm has a total of 158 workers. Let’s measure their productivity. In terms of profitability, gross margin is 69.15%, operating margin of -1439.5%, and the pretax margin is -1289.12%.
Caribou Biosciences Inc (CRBU) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Caribou Biosciences Inc is 12.58%, while institutional ownership is 58.66%.
Caribou Biosciences Inc (CRBU) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -20.17% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.50% during the next five years compared to -37.16% drop over the previous five years of trading.
Caribou Biosciences Inc (NASDAQ: CRBU) Trading Performance Indicators
Caribou Biosciences Inc (CRBU) is currently performing well based on its current performance indicators. A quick ratio of 7.38 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.65, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.84 in one year’s time.
Technical Analysis of Caribou Biosciences Inc (CRBU)
Analysing the last 5-days average volume posted by the [Caribou Biosciences Inc, CRBU], we can find that recorded value of 1.45 million was lower than the volume posted last year of 1.71 million. As of the previous 9 days, the stock’s Stochastic %D was 29.43%. Additionally, its Average True Range was 0.19.
During the past 100 days, Caribou Biosciences Inc’s (CRBU) raw stochastic average was set at 29.21%, which indicates a significant increase from 19.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 80.61% in the past 14 days, which was higher than the 77.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.07, while its 200-day Moving Average is $2.90. Now, the first resistance to watch is $2.11. This is followed by the second major resistance level at $2.20. The third major resistance level sits at $2.27. If the price goes on to break the first support level at $1.96, it is likely to go to the next support level at $1.89. Should the price break the second support level, the third support level stands at $1.80.
Caribou Biosciences Inc (NASDAQ: CRBU) Key Stats
Market capitalization of the company is 183.82 million based on 90,553K outstanding shares. Right now, sales total 34,480 K and income totals -102,070 K. The company made 2,020 K in profit during its latest quarter, and -34,680 K in sales during its previous quarter.
